Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

6 treatments under study, led by Lidocaine

Research Leaders

6 sponsors active, led by Milton S. Hershey Medical Center

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 65/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results50% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 3 (1)

Trial Status

Recruiting2
Terminated1
Completed1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT06439901Not ApplicableRecruitingPrimary

Optimizing Bronchopulmonary Cancer Screening

NCT00951366RecruitingPrimary

Preterm Lung Patient Registry

NCT03829618Phase 3Terminated

Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound

NCT03040193Not ApplicableCompletedPrimary

Nebulized Lignocaine for Topical Airway Anesthesia During Flexible Bronchoscopy: A Randomized Controlled Trial

Showing all 4 trials

Research Network

Common Treatments

  • Lidocaine2
  • Saline Nebulization1
  • Screening1
  • Inclusion1
  • Chest Ctscan And Followup1

Active Sponsors

  • Milton S. Hershey Medical Center1
  • Boston Children's Hospital1
  • Brigham and Women's Hospital1
  • Institut Mutualiste Montsouris1
  • Institut Curie1

Top Investigators

Related Conditions

  • Infiltrates1
  • Bronchiectasis Adult1
  • Cancer Lung1
  • Pneumonia1
  • Chestdiseases1

Activity Timeline